Home

yas Samimi Donatmak nf kappa b ppar disease model Duygu Voltaj içine bakmak

Frontiers | Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic  and Environmental Risk Factors from Cell to Humans
Frontiers | Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans

Regulation of peroxisome proliferator‐activated receptors (PPAR) α and ‐γ  of rat brain astrocytes in the course of activation by toll‐like receptor  agonists - Chistyakov - 2015 - Journal of Neurochemistry - Wiley Online  Library
Regulation of peroxisome proliferator‐activated receptors (PPAR) α and ‐γ of rat brain astrocytes in the course of activation by toll‐like receptor agonists - Chistyakov - 2015 - Journal of Neurochemistry - Wiley Online Library

Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases  by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology
Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology

Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis,  Thrombosis, and Vascular Biology
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology

Self-regulation of NF-κB activity and COX-2 expression. In inflammatory...  | Download Scientific Diagram
Self-regulation of NF-κB activity and COX-2 expression. In inflammatory... | Download Scientific Diagram

NF-κB - Wikipedia
NF-κB - Wikipedia

Frontiers | Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of  Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases
Frontiers | Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases

Therapeutic potential of PPARγ natural agonists in liver diseases - Wu -  2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Therapeutic potential of PPARγ natural agonists in liver diseases - Wu - 2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library

Cells | Free Full-Text | Role of NF-κB in Ageing and Age-Related Diseases:  Lessons from Genetically Modified Mouse Models | HTML
Cells | Free Full-Text | Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models | HTML

NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews  Immunology
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology

Therapeutic potential of PPARγ natural agonists in liver diseases
Therapeutic potential of PPARγ natural agonists in liver diseases

Frontiers | PPAR-γ Modulators as Current and Potential Cancer Treatments
Frontiers | PPAR-γ Modulators as Current and Potential Cancer Treatments

Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach  | Chemical Research
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast Database and a Deep Learning Artificial Neural Network Model-Based Approach | Chemical Research

Peroxisome Proliferator-Activated Receptor-γ Regulates the Expression of  Alveolar Macrophage Macrophage Colony-Stimulating Factor | The Journal of  Immunology
Peroxisome Proliferator-Activated Receptor-γ Regulates the Expression of Alveolar Macrophage Macrophage Colony-Stimulating Factor | The Journal of Immunology

Antioxidant mechanisms of peroxisome-proliferator-activated receptors.... |  Download Scientific Diagram
Antioxidant mechanisms of peroxisome-proliferator-activated receptors.... | Download Scientific Diagram

PPAR Regulation of Inflammatory Signaling in CNS Diseases
PPAR Regulation of Inflammatory Signaling in CNS Diseases

Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for  Antiparkinsonism Therapeutics | ACS Chemical Neuroscience
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics | ACS Chemical Neuroscience

Cells | Free Full-Text | PPAR-Mediated Toxicology and Applied Pharmacology  | HTML
Cells | Free Full-Text | PPAR-Mediated Toxicology and Applied Pharmacology | HTML

Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental  Targeting for the Treatment of Inflammatory Bowel Diseases
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

Frontiers | Neuronal Gene Targets of NF-κB and Their Dysregulation in  Alzheimer's Disease
Frontiers | Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease

NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene

NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy

Macrophage nuclear receptors: Emerging key players in infectious diseases |  PLOS Pathogens
Macrophage nuclear receptors: Emerging key players in infectious diseases | PLOS Pathogens

Frontiers | The Protective Effects of Peroxisome Proliferator-Activated  Receptor Gamma in Cerebral Ischemia-Reperfusion Injury
Frontiers | The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury

NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy